Skip to content

NeuroBo Pharmaceuticals

Request correction

NeuroBo Pharmaceuticals is a company based in Cambridge, United States.

Last updated September 1, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

NeuroBo Pharmaceuticals is a company located in Cambridge, United States.

History

NeuroBo Pharmaceuticals is a company in Cambridge, United States.

Recent events

  • Reported

    NeuroBo appoints Gil Price as president and CEO[2]

    NeuroBo Pharmaceuticals announced that it appointed Gil Price as president and chief executive officer. Price will replace Richard J. Kang, who was to step down later that month while remaining on the board.

  • Reported

    NeuroBo completes $10 million private placement[3]

    NeuroBo reported the successful completion of a private placement of 2.5 million common shares and warrants, with aggregate gross proceeds of $10.0 million and net proceeds of approximately $9.2 million. The source dates this completion to the first quarter of 2021.

  • Reported

    NeuroBo acquires ANA Therapeutics[4]

    NeuroBo Pharmaceuticals acquired ANA Therapeutics on December 31, 2020. ANA became a wholly owned subsidiary of NeuroBo.

  • Reported

    NeuroBo appoints Douglas J. Swirsky to its board[5]

    NeuroBo Pharmaceuticals appointed Douglas J. Swirsky to its Board of Directors, effective September 1, 2020; he will also serve on the Audit Committee.

  • Reported

    NeuroBo reports first-quarter 2020 results[6]

    NeuroBo Pharmaceuticals announced financial results for the first quarter ended March 31, 2020, reporting a net loss of approximately $4.8 million and cash and cash equivalents of $9.8 million as of March 31.

Read more

Sources9 sources

Cite this profile: Cite the canonical profile. /brand-wiki/neurobo-pharmaceuticals · Editorial policy · How profiles are compiled